Related Experiment Videos
Practical follow-up guidelines for patients treated with amiodarone
1Harvard School of Public Health, Boston, Massachusetts.
Clinical Cardiology
|July 1, 1987
Summary
Amiodarone, an antiarrhythmic drug, requires a 1-2 month loading period for efficacy. Careful monitoring is essential due to potential serious side effects impacting cardiac, pulmonary, neurologic, and thyroid functions.
Area of Science:
- Pharmacology
- Cardiology
- Clinical Therapeutics
Background:
- Amiodarone is an antiarrhythmic medication for severe ventricular arrhythmias.
- Its unique properties include poor absorption and binding to adipose tissue.
Purpose of the Study:
- To outline the therapeutic considerations for amiodarone use.
- To highlight the importance of monitoring for efficacy and toxicity.
Main Methods:
- Pharmacokinetic properties influencing drug concentration and efficacy.
- Clinical efficacy assessment via ambulatory monitoring and electrophysiologic (EP) studies.
- Monitoring for amiodarone-induced side effects across multiple organ systems.
Main Results:
- A 1-2 month loading dose period is necessary to achieve therapeutic tissue concentrations.
- Suppression of ventricular tachycardia (VT) on ambulatory monitoring correlates with efficacy.
- Serious side effects occur in 18% of patients, often requiring discontinuation.
Conclusions:
- Amiodarone therapy requires a delayed onset evaluation (1-2 months).
- Electrophysiologic study findings like continued inducibility do not predict recurrence.
- Continuous patient monitoring for efficacy and toxicity is crucial due to potential serious adverse events.